Search - tctmd.com

Displaying 21 - 40 of 42

Sort: Relevancy | Date

News Daily News

FDA Provides Update on Tainted ARB Investigation, With New Impurity Found

Todd Neale

March 04, 2019

News Daily News

FDA Adds Boxed Warning About CV Risks to Gout Drug Febuxostat

Shelley Wood

February 22, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2019

Caitlin E. Cox

January 31, 2019

News Daily News

More Blood-Pressure Drugs Recalled Due to Cancer-Causing Impurities

Shelley Wood

December 10, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2018

Shelley Wood

November 30, 2018

News Daily News

FDA Warns of Stroke and Arterial Dissection Risk With MS Drug

L.A. McKeown

November 29, 2018

News Daily News

INR Test Strips Recalled Due to Inaccurate Measurements

Todd Neale

November 02, 2018

News Daily News

FDA: Contaminated Irbesartan Now Under Voluntary Recall

Michael O'Riordan

October 31, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2018

Caitlin E. Cox

September 04, 2018

News Daily News

Abciximab in ‘Short Supply’ Worldwide

Shelley Wood

April 13, 2018

News Daily News

Recall: Clopidogrel Tablets Mislabeled, May Contain Statin

L.A. McKeown

January 11, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2017

Shelley Wood

October 29, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2017

Shelley Wood

September 30, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2017

Shelley Wood

June 01, 2017

News Daily News

TCTMD’s Top 10 Most Popular Stories for April 2017

Shelley Wood

April 28, 2017

News Daily News

Alirocumab to Remain On Market While Companies Clash Over Patents

Michael O'Riordan

February 09, 2017

News Daily News

FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors

Michael O'Riordan

August 18, 2016

News Daily News

Experimental FAAH Inhibitors Do Not Pose Safety Risk, FDA Concludes

Michael O'Riordan

August 12, 2016

News Daily News

USPSTF: Not Enough Evidence to Recommend Routine Lipid Screening in Children and Adolescents

Michael O'Riordan

August 09, 2016

News Daily News

FDA:凝血监测系统四面楚歌、境况堪忧

Todd Neale

July 13, 2016

Advertisement

FDA Provides Update on Tainted ARB Investigation, With New Impurity Found

FDA Adds Boxed Warning About CV Risks to Gout Drug Febuxostat

TCTMD’s Top 10 Most Popular Stories for January 2019

More Blood-Pressure Drugs Recalled Due to Cancer-Causing Impurities

TCTMD’s Top 10 Most Popular Stories for November 2018

FDA Warns of Stroke and Arterial Dissection Risk With MS Drug

INR Test Strips Recalled Due to Inaccurate Measurements

FDA: Contaminated Irbesartan Now Under Voluntary Recall

TCTMD’s Top 10 Most Popular Stories for August 2018

Abciximab in ‘Short Supply’ Worldwide

Recall: Clopidogrel Tablets Mislabeled, May Contain Statin

TCTMD’s Top 10 Most Popular Stories for October 2017

TCTMD’s Top 10 Most Popular Stories for September 2017

TCTMD’s Top 10 Most Popular Stories for May 2017

TCTMD’s Top 10 Most Popular Stories for April 2017

Alirocumab to Remain On Market While Companies Clash Over Patents

FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors

Experimental FAAH Inhibitors Do Not Pose Safety Risk, FDA Concludes

USPSTF: Not Enough Evidence to Recommend Routine Lipid Screening in Children and Adolescents

FDA:凝血监测系统四面楚歌、境况堪忧

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content